Polyrizon Ltd. (PLRZ)
NASDAQ: PLRZ · Real-Time Price · USD
10.99
-0.04 (-0.36%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Polyrizon Market Cap
Polyrizon has a market cap or net worth of $23.13 million as of September 18, 2026. Its market cap has increased by 285.55% in one year.
Market Cap
23.13M
Enterprise Value
10.85M
1-Year Change
285.55%
Ranking
Category
Stock Price
$10.99
ChartMarket Cap Chart
Since the IPO on October 29, 2024, Polyrizon's market cap has increased from $6.50M to $23.13M, an increase of 255.76%. That is a compound annual growth rate of 95.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 23.13M | 70.90% |
| Dec 31, 2025 | 13.53M | 48.69% |
| Dec 31, 2024 | 9.10M | 40.00% |
| Oct 29, 2024 | 6.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Psyence Biomedical | 25.27M |
| Radiopharm Theranostics | 24.67M |
| Actuate Therapeutics | 23.56M |
| Cocrystal Pharma | 23.31M |
| Estrella Immunopharma | 23.01M |
| Cellectar Biosciences | 22.50M |
| Atossa Therapeutics | 22.15M |
| GridAI Technologies | 22.02M |